Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2018 3
2019 2
2020 2
2021 2
2022 1
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Lancet. 2024 Jun 22;403(10445):2695-2708. doi: 10.1016/S0140-6736(24)00821-3. Epub 2024 May 22. Lancet. 2024. PMID: 38795719 Clinical Trial.
Upper- vs Lower-Extremity Secondary Access During Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial.
Versteeg GAA, Rooijakkers MJP, Hemelrijk KI, Vlaar PJ, Overduin DC, van Wely MH, Aarts HM, van Ginkel DJ, van Nunen LX, van Geuns RJ, van Garsse LAFM, Geuzebroek GSC, Verkroost MWA, Cetinyurek-Yavuz A, Heijmen RH, Ten Berg JM, Tonino PAL, Delewi R, van Royen N. Versteeg GAA, et al. Among authors: verkroost mwa. JAMA Netw Open. 2024 Oct 1;7(10):e2438578. doi: 10.1001/jamanetworkopen.2024.38578. JAMA Netw Open. 2024. PMID: 39412806 Free PMC article. Clinical Trial.
Transcatheter aortic valve implantation amid the COVID-19 pandemic: a nationwide analysis of the first COVID-19 wave in the Netherlands.
Rooijakkers MJP, Li WWL, Stens NA, Vis MM, Tonino PAL, Timmers L, Van Mieghem NM, den Heijer P, Kats S, Stella PR, Roolvink V, van der Werf HW, Stoel MG, Schotborgh CE, Amoroso G, Porta F, van der Kley F, van Wely MH, Gehlmann H, van Garsse LAFM, Geuzebroek GSC, Verkroost MWA, Mourisse JM, Medendorp NM, van Royen N. Rooijakkers MJP, et al. Among authors: verkroost mwa. Neth Heart J. 2022 Nov;30(11):503-509. doi: 10.1007/s12471-022-01704-9. Epub 2022 Jun 1. Neth Heart J. 2022. PMID: 35648264 Free PMC article.
Diastolic delta best predicts paravalvular regurgitation after transcatheter aortic valve replacement as assessed by cardiac magnetic resonance: the APPOSE trial.
Rooijakkers MJP, Stens NA, van Wely MH, van der Wulp K, Rodwell L, Gehlmann H, van Garsse LAFM, Geuzebroek GSC, Verkroost MWA, Habets J, El Messaoudi S, Thijssen DHJ, Nijveldt R, van Royen N. Rooijakkers MJP, et al. Among authors: verkroost mwa. Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):1072-1081. doi: 10.1093/ehjci/jead033. Eur Heart J Cardiovasc Imaging. 2023. PMID: 36915984 Free PMC article. Clinical Trial.
Procedural Success and Clinical Outcome of the Portico Transcatheter Aortic Valve Using the Left Subclavian Artery as Primary Access.
van Wely MH, van der Wulp K, Verkroost MWA, Gehlmann H, Kievit PC, van Garsse LAFM, Morshuis WJ, van Royen N. van Wely MH, et al. Among authors: verkroost mwa. JACC Cardiovasc Interv. 2018 Jul 9;11(13):1311-1312. doi: 10.1016/j.jcin.2018.04.029. JACC Cardiovasc Interv. 2018. PMID: 29976369 Free article. No abstract available.
Feasibility and Outcomes of Transcatheter Aortic Valve Implantation Using the Left Axillary Artery as Primary Access Site.
van der Wulp K, Verkroost MWA, van Wely MH, Gehlmann HR, Van Garsse LAFM, Noyez L, Brouwer MA, Kievit PC, De Boer MJ, Suryapranata H, Morshuis WJ, van Royen N. van der Wulp K, et al. Among authors: verkroost mwa. Ann Thorac Surg. 2019 Feb;107(2):546-552. doi: 10.1016/j.athoracsur.2018.07.093. Epub 2018 Oct 4. Ann Thorac Surg. 2019. PMID: 30292844
Crossing coronary arteries.
Zegers ES, Verkroost MW, Verheugt FW. Zegers ES, et al. Neth Heart J. 2007;15(4):155-6. doi: 10.1007/BF03085973. Neth Heart J. 2007. PMID: 17612677 Free PMC article. No abstract available.
Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trial.
Rooijakkers MJP, Versteeg GAA, Hemelrijk KI, Aarts HM, Overduin DC, van Ginkel DJ, Vlaar PJ, van Wely MH, van Nunen LX, van Geuns RJ, van Garsse LAFM, Geuzebroek GSC, Verkroost MWA, Rodwell L, Heijmen RH, Tonino PAL, Ten Berg JM, Delewi R, van Royen N. Rooijakkers MJP, et al. Among authors: verkroost mwa. Neth Heart J. 2024 Aug;32(7-8):270-275. doi: 10.1007/s12471-024-01869-5. Epub 2024 Apr 23. Neth Heart J. 2024. PMID: 38653922 Free PMC article.
14 results